Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Mol Immunol. 2009 Mar 14;46(8-9):1647–1653. doi: 10.1016/j.molimm.2009.02.021

Figure 4.

Figure 4

Effect of insertion of a KDN tripeptide in a fHbp from the antigenic variant 1 group (v.1) on reactivity with anti-fHbp mAb JAR 4. The KDN sequence at residues 67-69 was naturally present only in fHbp in the variant 3 group. A, Binding of JAR 4. B, Binding of a control anti-fHbp mAb, JAR 5 (see Legend to Figure 1).